World’s Most Expensive Drug Is Now $4.25 Million Gene Therapy

March 20, 2024, 2:09 PM UTC

A new gene therapy for an ultra-rare disease will have a wholesale cost of $4.25 million, making it the world’s most expensive drug.

The one-time treatment, Lenmeldy, won US regulatory approval on Monday to correct the underlying cause of a hereditary condition called early-onset metachromatic leukodystrophy, or MLD.

MLD is a fatal disease in which infants sometimes start to lose the ability to walk and talk. Orchard Therapeutics said the drug’s price “reflects its clinical, economic and societal value” in a statement Wednesday.

Read More: Gene Therapy Was Hailed as a Revolution. Then Came the Bill.

The drug’s cost ...

Learn more about Bloomberg Government or Log In to keep reading:

Learn About Bloomberg Government

Providing news, analysis, data and opportunity insights.

Already a subscriber?

Log in to keep reading or access research tools.